CorMedix (NASDAQ:CRMD) Given New $12.00 Price Target at Royal Bank of Canada
CorMedix (NASDAQ:CRMD – Free Report) had its target price lifted by Royal Bank of Canada from $11.00 to $12.00 in a report released on Thursday morning,Benzinga reports. They currently have an outperform rating on the stock. Several other equities analysts also recently issued reports on CRMD. Truist Financial upped their target price on CorMedix from […]
More Stories
Trump Threatens to Invoke Insurrection Act to End Anti-ICE Protests in Minnesota
By Sam Dorman President Donald Trump has threatened to use the Insurrection Act in Minnesota following an attack on an...
How ICE Was Targeted in Minneapolis for Weeks Before Fatal Shooting
By Jacki Thrapp MINNEAPOLIS—Activists in Minneapolis are continuing to organize efforts to impede immigration enforcement as the Trump administration surges...
Trump Says US Control of Greenland Would Make NATO Stronger
By Tom Ozimek President Donald Trump said on Jan. 14 that NATO would be a stronger and more credible deterrent...
Constraining Mega-Landlords Would Help Some Buyers, Won’t Solve Housing Woes: Industry Insiders
By Petr Svab President Donald Trump’s proposed ban on large corporate landlords buying more single-family homes could help families looking...
DHS Calls on Minnesota to Honor ICE Arrest Detainers of More Than 1,360 Criminal Illegal Aliens
By Naveen Athrappully The U.S. Department of Homeland Security (DHS) called on Governor Tim Walz and Minneapolis Mayor Jacob Frey...
Greenlandic, Danish Ministers to Meet With Vance, Rubio in Washington: Rasmussen
By Victor Friedman Danish Foreign Minister Lars Lokke Rasmussen said that he and his Greenlandic counterpart, Vivian Motzfeldt, will meet...